API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Historical End-of-Day API Real-time Prices API Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 152 articles Forum Github 14 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. SHE /
  3. 300147.SHE

Xiangxue Pharmaceutical (300147 SHE) stock market data APIs

¥12.89 0.82(6.8%) as of November 22, 2024
Price chart is built with Anychart

Xiangxue Pharmaceutical Co., Ltd. engages in the research and development, procurement, manufacture, delivery, and distribution of pharmaceutical products in China. It offers antivirotic oral liquids under the Xiangxue brand name; and healthcare supplements, as well as health solutions, such as food and beverage. Xiangxue Pharmaceutical Co., Ltd. has strategic partnership agreement with 111, Inc. to develop the Internet + Medicine model for China's traditional Chinese medicine industry. Xiangxue Pharmaceutical Co., Ltd. was founded in 1997 and is based in Guangzhou, China.

Xiangxue Pharmaceutical Financial Data Overview

12.07
12.89
-
13.13
11.95
3-16.49
8 359 M
661 M
2 105 M
-0.1254
0.518
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '300147',
Type: 'Common Stock',
Name: 'Xiangxue Pharmaceutical',
Exchange: 'SHE',
CurrencyCode: 'CNY',
CurrencyName: 'Renminbi',
CurrencySymbol: '¥',
CountryName: 'China',
CountryISO: 'CN',
OpenFigi: NULL,
ISIN: 'CNE100000Y92',
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: '2010-12-15',
InternationalDomestic: 'International',
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Xiangxue Pharmaceutical Fundamental Data is available in our Financial Data APIs

  • Net Revenue 2 105 M
  • EBITDA 140 M
  • Earnings Per Share -0.7
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Xiangxue Pharmaceutical Earnings via APIs

  • Latest Release 2024-10-26
  • EPS/Forecast NaN

Get Xiangxue Pharmaceutical End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Xiangxue Pharmaceutical latest news via APIs

Athenex Announces FDA Approval of Klisyri® (Tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp

Klisyri® is the first FDA approved proprietary product for Athenex First-in-class microtubule inhibitor indicated for the topical treatment of actinic keratosis (AK) on the face or scalp with a 5-da...
  • ACTINIC KERATOSIS
  • AK
  • ALMIRALL
  • APPLICATION
  • ATHENEX
  • DRUG DEVELOPMENT
  • FDA
  • INC
  • MICROTUBULE INHIBITOR
  • TOPICAL TREATMENT
  • TREATMENT OF CANCER

Athenex Announces FDA Approval of Klisyri® (Tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp

Klisyri® is the first FDA approved proprietary product for Athenex First-in-class microtubule inhibitor indicated for the topical treatment of actinic keratosis (AK) on the face or scalp with a 5-da...
  • ACTINIC KERATOSIS
  • AK
  • ALMIRALL
  • APPLICATION
  • ATHENEX
  • DRUG DEVELOPMENT
  • FDA
  • INC
  • MICROTUBULE INHIBITOR
  • TOPICAL TREATMENT
  • TREATMENT OF CANCER
News API is available at any package from $19.99 See full price
Get sample of News API
Do you have any questions?
support@eodhistoricaldata.com